Inspire Medical Systems Inc (INSP)
158.79
+4.42
(+2.86%)
USD |
NYSE |
May 31, 16:00
158.90
+0.11
(+0.07%)
Pre-Market: 20:00
Inspire Medical Systems Research and Development Expense (Quarterly): 28.85M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 28.85M |
| December 31, 2023 | 31.05M |
| September 30, 2023 | 29.14M |
| June 30, 2023 | 30.82M |
| March 31, 2023 | 25.52M |
| December 31, 2022 | 21.25M |
| September 30, 2022 | 20.99M |
| June 30, 2022 | 14.53M |
| March 31, 2022 | 11.87M |
| December 31, 2021 | 10.29M |
| September 30, 2021 | 9.614M |
| June 30, 2021 | 9.288M |
| March 31, 2021 | 8.154M |
| December 31, 2020 | 7.285M |
| September 30, 2020 | 7.307M |
| Date | Value |
|---|---|
| June 30, 2020 | 6.062M |
| March 31, 2020 | 5.438M |
| December 31, 2019 | 3.767M |
| September 30, 2019 | 3.623M |
| June 30, 2019 | 2.846M |
| March 31, 2019 | 2.603M |
| December 31, 2018 | 2.152M |
| September 30, 2018 | 1.771M |
| June 30, 2018 | 1.735M |
| March 31, 2018 | 1.73M |
| December 31, 2017 | 1.682M |
| September 30, 2017 | 1.176M |
| June 30, 2017 | 1.743M |
| March 31, 2017 | 1.593M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.846M
Minimum
Jun 2019
31.05M
Maximum
Dec 2023
14.39M
Average
9.954M
Median
Research and Development Expense (Quarterly) Benchmarks
| Conmed Corp | 13.59M |
| Nevro Corp | 14.83M |
| Stereotaxis Inc | 2.243M |
| Electromed Inc | 0.167M |
| Myomo Inc | 0.9562M |